Purpose

This toolkit gives healthcare leaders a ready-to-use governance system for adopting artificial intelligence (AI) responsibly. It replaces guesswork and ad-hoc decisions with clear structures: a committee charter, defined roles, risk and vendor checklists, procurement questions, readiness and oversight tools, incident reporting, bias and safety review, a policy template, and a 30/60/90-day roadmap. Everything here is designed to be copied, edited, and put into use immediately.

Who Should Use This Toolkit

This toolkit is built for executives and leaders who are responsible for, or affected by, AI decisions in a healthcare setting, including: chief executives, chief medical and nursing officers, chief information and digital officers, compliance and privacy officers, patient experience and quality leaders, information security teams, clinical informatics leaders, and department directors evaluating AI tools. Patient and family advisory council leaders will also find the oversight and transparency sections useful.

Why Responsible AI Governance Matters

AI is moving quickly into documentation, triage, imaging support, scheduling, patient messaging, and decision support. Used well, it can reduce administrative burden and support better care. Used without oversight, it can introduce bias, expose protected health information, automate errors at scale, and erode patient and clinician trust.

Governance is how a leadership team keeps AI safe, fair, transparent, and accountable. National frameworks make the expectation clear: the U.S. National Institute of Standards and Technology (NIST) AI Risk Management Framework organizes responsible AI around four functions — Govern, Map, Measure, and Manage — and the World Health Organization has published guidance on the ethics and governance of AI for health. This toolkit translates those principles into a working system your organization can run.

The core idea is simple: no AI tool touches patients, clinicians, or protected data without a named owner, a documented risk review, human oversight, and a way to report and fix problems.

Executive Summary

Responsible AI governance is not a one-time approval; it is an ongoing leadership function. This toolkit establishes that function in five moves:

1. Stand up a committee with a clear charter and accountable roles (Sections 1–2).
2. Evaluate before you adopt using structured risk, vendor, procurement, and readiness assessments (Sections 3–6).
3. Build in safety and fairness through incident reporting, bias and safety review, and human oversight (Sections 7–9).
4. Set the rules with an organizational AI policy (Section 10).
5. Sequence the work with a 30/60/90-day roadmap and a one-page executive briefing (Sections 11–12).

Each section below is a working template. Edit the bracketed fields, delete what does not apply, and adopt the rest.

1. AI Governance Committee Charter (Template)

Edit the bracketed fields to fit your organization.

Committee name: [Organization] AI Governance Committee

Purpose: To ensure all AI used in [Organization] is safe, effective, fair, transparent, secure, and aligned with our mission and with patient and clinician interests.

Scope: All AI and algorithmic tools that influence clinical care, operations, patient communication, or the handling of protected health information — whether built in-house, embedded in a vendor product, or accessed as a service.

Authority: The committee may approve, pause, require changes to, or retire any AI tool within scope. It reports to [executive sponsor / board committee].

Core responsibilities:

• Maintain an inventory of all AI tools in use or under evaluation.
• Require and review a risk assessment before any AI tool goes live.
• Set policy and approve exceptions.
• Monitor performance, bias, and safety after deployment.
• Oversee incident reporting and response.
• Ensure human oversight is defined for every clinical use.

Membership: Executive sponsor (chair), clinical leadership, IT/security, compliance/privacy, legal, quality/patient safety, patient experience, data/informatics, and a patient or community representative.

Meeting cadence: [Monthly] for standing review; ad hoc for urgent risk or incident decisions.

Quorum and decisions: [Majority] present; high-risk decisions require the chair plus clinical, compliance, and security representatives.

Documentation: All decisions, approvals, and exceptions are recorded and retained per [records policy].

Review: This charter is reviewed at least annually.

2. Committee Roles & Responsibilities (RACI)

R = Responsible · A = Accountable · C = Consulted · I = Informed

3. AI Risk Assessment Checklist

Complete before any AI tool is approved. Mark each item Yes / No / Needs work.

• The problem the tool solves and the intended users are clearly defined.
• The tool’s outputs and their influence on decisions are documented.
• The data the tool uses (and where it is stored/processed) is identified.
• Protected health information exposure has been assessed and minimized.
• A privacy and security review is complete (see Section 4).
• Potential for bias across patient populations has been evaluated.
• Failure modes and worst-case harms have been identified.
• Human oversight is defined: who reviews outputs and when (see Section 9).
• Performance has been validated on data representative of our patients.
• A monitoring plan exists for accuracy, bias, and drift after launch.
• A rollback / shutoff plan exists if the tool fails or causes harm.
• Regulatory status is understood (e.g., whether it is a regulated medical device).
• An accountable owner is named.
• Overall risk rating: Low / Medium / High, with justification.

4. AI Vendor Evaluation Checklist

• Vendor clearly explains what the model does and its intended use.
• Vendor discloses training data sources and known limitations.
• Vendor provides performance and, where relevant, bias/fairness testing results.
• Vendor specifies whether outputs are validated by clinicians.
• Data handling: where data is stored, who can access it, and whether our data is used to train their models.
• Security posture documented (encryption, access controls, certifications such as SOC 2 / HITRUST).
• A Business Associate Agreement (BAA) is available where PHI is involved.
• Vendor supports human oversight and an override path.
• Update, versioning, and change-notification process is defined.
• Incident notification commitments and timelines are stated.
• Exit plan: data export and deletion on contract end.
• References from comparable healthcare organizations are available.

5. AI Procurement Questions

Send these to any AI vendor before purchase:

1. What specific task does your AI perform, and what does it not do?
2. What data was the model trained on, and how representative is it of diverse patient populations?
3. How is accuracy measured, and what were the results in healthcare settings?
4. Have you tested for bias across age, race, sex, language, and disability? What did you find?
5. Is the product regulated as a medical device? If so, what is its clearance/approval status?
6. Where is our data stored and processed, and is it ever used to train your models?
7. Will you sign a BAA, and what security certifications do you hold?
8. How does a clinician review, override, or turn off the output?
9. How and when will you notify us of model updates that change behavior?
10. What is your process and timeline for reporting safety incidents to us?
11. What support do you provide for implementation and monitoring?
12. What happens to our data when the contract ends?

6. AI Implementation Readiness Assessment

Confirm the organization is ready before go-live. Rate each as Ready / Partial / Not ready.

• Sponsorship: An executive owner and accountable committee are in place.
• Workflow fit: The tool fits a real workflow; staff know where it starts and stops.
• Training: Users are trained on what the tool does, its limits, and how to override it.
• Human oversight: Review points and responsible roles are defined and staffed.
• Data & integration: Required integrations are tested; data quality is sufficient.
• Privacy & security: Reviews complete; access controls and BAA in place.
• Monitoring: Metrics, owners, and a review cadence are defined.
• Communication: Plan for informing staff and, where appropriate, patients.
• Contingency: Rollback and downtime procedures are documented.
• Pilot: A limited pilot with success criteria is planned before full rollout.

7. AI Incident Reporting Template

High and Critical incidents are escalated to the committee chair and clinical/compliance leads the same day.

8. AI Bias & Safety Review Checklist

• The patient populations the tool will affect are identified.
• Performance has been checked across relevant groups (age, race/ethnicity, sex, primary language, disability, payer).
• Differences in performance across groups are documented and explained.
• Data gaps that could disadvantage any group are identified.
• The tool does not use sensitive attributes as inappropriate proxies.
• Worst-case harms (false positives/negatives) are mapped to safeguards.
• Clinicians can see when and why the tool may be uncertain or wrong.
• A plan exists to monitor for bias and performance drift over time.
• A threshold is defined that triggers pause and re-review.
• Affected patients are treated fairly and equitably under the tool’s use.

9. AI Human Oversight Checklist

For every clinical or patient-facing AI use, confirm:

• A qualified human reviews outputs before they affect a patient (human-in-the-loop) or a clear monitoring and intervention plan exists (human-on-the-loop), as appropriate to risk.
• The responsible role for review is named and staffed.
• Reviewers are trained on the tool’s limits and how it can fail.
• Overriding or rejecting an AI output is easy and recorded.
• The tool is positioned as decision support, not a replacement for clinical judgment.
• There is a way to turn the tool off quickly if needed.
• Oversight effectiveness is reviewed periodically (not assumed).

10. AI Policy Template

Policy title: Responsible Use of Artificial Intelligence at [Organization]

Purpose: To define how AI is selected, approved, used, and monitored so that it is safe, fair, transparent, secure, and accountable.

Scope: All staff, contractors, and vendors using AI that affects clinical care, operations, patient communication, or protected data.

Principles: Patient safety first; fairness and non-discrimination; privacy and security; transparency; human accountability; and continuous monitoring.

Requirements:

• No AI tool within scope is used without committee approval and a completed risk assessment.
• Every approved tool has a named owner and defined human oversight.
• PHI is only used with appropriate agreements and security controls.
• Staff must report AI incidents promptly using the incident template.
• AI outputs do not override clinical judgment.
• Patients are informed about AI use where it is appropriate and required.
• All approved tools are monitored for accuracy, bias, and safety.

Roles: Reference the committee charter and RACI (Sections 1–2).

Enforcement: Non-compliance is addressed under [HR / compliance policy].

Review: This policy is reviewed at least annually and updated as guidance and regulation evolve.

11. AI Governance Roadmap (30 / 60 / 90 Day)

Days 1–30 — Establish:

• Name an executive sponsor and form the governance committee.
• Adopt the charter and RACI.
• Build a first inventory of AI tools already in use.
• Approve the AI policy in draft.

Days 31–60 — Assess:

• Run risk assessments on the highest-impact tools already in use.
• Apply the vendor and procurement checklists to anything under consideration.
• Define human oversight for each clinical use.
• Stand up the incident reporting process.

Days 61–90 — Operationalize:

• Finalize and publish the AI policy.
• Begin post-deployment monitoring (accuracy, bias, safety).
• Run a bias & safety review on a priority tool.
• Set the standing review cadence and report to leadership/board.

12. One-Page Executive Summary

References

1. National Institute of Standards and Technology. Artificial Intelligence Risk Management Framework (AI RMF 1.0). NIST AI 100-1, 2023.
2. World Health Organization. Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. 2021 (and 2024 guidance on large multi-modal models).
3. Office of the National Coordinator for Health IT (HHS). Health Data, Technology, and Interoperability (HTI-1) Final Rule — algorithm transparency provisions. 2024.
4. Agency for Healthcare Research and Quality (AHRQ). Resources on health equity and bias in healthcare algorithms.
5. U.S. Food and Drug Administration. Artificial Intelligence/Machine Learning-Based Software as a Medical Device guidance and resources.

Verify the current version and URL of each source at time of use; titles and editions are updated periodically by the issuing bodies.

Related Care Experience Lab Resources

• AI for Healthcare Leaders
• Healthcare Communication Transformation
• Explore the full Resource Library

Version 1.0 · Review date: [set at publication] · Care Experience Lab · Responsible AI in Healthcare. This toolkit is provided for general informational purposes and is not legal, compliance, or clinical advice; adapt it to your organization’s policies and applicable law.